<?xml version='1.0' encoding='utf8'?><data><item><title>The first change of seasons without a mask… Thorough preparation for ‘flu and pneumonia’</title><link>https://www.archyde.com/the-first-change-of-seasons-without-a-mask-thorough-preparation-for-flu-and-pneumonia/</link><ns0keywords>flu and pneumonia,risk,change of seasons,patients,pneumococcal,mask,diseases,infection,preparation for flu,stable phase,people,korea</ns0keywords><pubDate>Fri, 31 Mar 2023 02:16:00 +0200</pubDate><guid isPermaLink="false">archyde-1ef595e951d29fb977913687ff848e5a</guid><source country="US" url="https://www.archyde.com/">archyde</source><ns1language>en</ns1language><category ns0trigger="Pneumococcal[1]; pneumococcal[6]; ">PneumococcalInfection</category><category>Influenza</category><category>Pneumonia</category><category>CoronavirusInfection</category><ns0entity id="2252084" name="Centers for Disease Control">Centers for Disease Control</ns0entity><ns0entity id="678690" name="Centers for Disease Control and Prevention">Centers for Disease Control and Prevention</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><georss>33.87529 -117.56644</georss></item><item><title>Caso de meningite é confirmado em criança em Maceió; infectologista diz que casos são pontuais</title><link>https://g1.globo.com/al/alagoas/noticia/2023/03/30/caso-de-meningite-e-confirmado-em-crianca-em-maceio-infectologista-diz-que-casos-sao-pontuais.ghtml</link><ns0keywords>doença meningocócica,secretaria municipal,saúde,caso de meningite,meningite é confirmado,infectologista fernando maia,criança em maceió,confirmado em criança,casos são pontuais</ns0keywords><pubDate>Fri, 31 Mar 2023 02:05:00 +0200</pubDate><guid isPermaLink="false">g1-globo-b98a620f2ef62374bdc866cc3b7042e0</guid><source country="BR" url="http://g1.globo.com/dynamo/rss2.xml">g1-globo</source><ns1language>pt</ns1language><category>HaemophilusinfluenzaeInfection</category><category ns0trigger="Streptococcus[1]; pneumoniae[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>HepatitisB</category><category>vaccination_gen</category><category>Meningitis</category><category>VaccinationAdverseEffects</category><ns0entity id="947475" name="Fernando Maia">Fernando Maia</ns0entity><georss>-9.66583 -35.73528</georss></item><item><title>Pope Francis, the disease that struck the Pontiff has been revealed</title><link>https://www.breakinglatest.news/health/pope-francis-the-disease-that-struck-the-pontiff-has-been-revealed/</link><ns0keywords>pope francis,infectious bronchitis,gemelli polyclinic,struck the pontiff,holy father,respiratory,rome revealed,disease that struck,rome have revealed,polyclinic in rome,symptoms,chronic,note</ns0keywords><pubDate>Thu, 30 Mar 2023 23:58:00 +0200</pubDate><guid isPermaLink="false">breakinglatest-eac83b6d8076cd8a48f4e1760d34cc4d</guid><source country="US" url="https://www.breakinglatest.news/category/business/">breakinglatest</source><ns1language>en</ns1language><category>HaemophilusinfluenzaeInfection</category><category ns0trigger="Streptococcus[1]; pneumoniae[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>RespiratorySyndrome</category><ns0entity id="140854" name="Pope Francis">Pope Francis</ns0entity><georss>41.89193 12.51133</georss></item><item><title>SUTRO BIOPHARMA, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)</title><link>https://www.marketscreener.com/quote/stock/SUTRO-BIOPHARMA-INC-46353309/news/SUTRO-BIOPHARMA-INC-Management-s-Discussion-and-Analysis-of-Financial-Condition-and-Results-of-Op-43386449/</link><ns0keywords>sutro biopharma,clinical,luvelta,product candidates,development,research,financial condition,phase 1 trial,performance,results of operations,costs</ns0keywords><pubDate>Thu, 30 Mar 2023 22:47:00 +0200</pubDate><guid isPermaLink="false">4-traders-b0f5f43c46e32a0d146ca575d787ccad</guid><source country="FR" url="https://www.marketscreener.com/news/companies/">4-traders</source><ns1language>en</ns1language><category>Toxic</category><category ns0trigger="pneumococcal[2]; ">PneumococcalInfection</category><category>Communicabledisease</category><ns0entity id="380486" name="Drug Administration">Drug Administration</ns0entity><ns0entity id="2630043" name="EMD Serono">EMD Serono</ns0entity><ns0entity id="2003159" name="American Society">American Society</ns0entity><ns0entity id="2256315" name="Option Agreement">Option Agreement</ns0entity><ns0entity id="70670" name="Annual Meeting">Annual Meeting</ns0entity><georss>39.90750 116.39723</georss></item><item><title>Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones</title><link>https://www.wallstreet-online.de/nachricht/16750416-sutro-biopharma-reports-full-year-2022-financial-results-business-highlights-and-select-anticipated-milestones</link><ns0keywords>vaxcyte common stock,million,select anticipated milestones,sutro biopharma reports,development,results,reports full year,full year 2022,clinical,company's,year 2022 financial,greater china,chief medical officer</ns0keywords><pubDate>Thu, 30 Mar 2023 22:41:00 +0200</pubDate><guid isPermaLink="false">wallstreet-online-8141e08548f1ea344ebf16029316b64b</guid><source country="DE" url="https://www.wallstreet-online.de/rss/nachrichten-weitere-nachrichten.xml">wallstreet-online</source><ns1language>en</ns1language><category ns0trigger="pneumococcal[4]; ">PneumococcalInfection</category><category>GM_animals</category><category>CoronavirusInfection</category><ns0entity id="380486" name="Drug Administration">Drug Administration</ns0entity><ns0entity id="719529" name="Carlos Lugo">Carlos Lugo</ns0entity><ns0entity id="2878445" name="Chief Business">Chief Business</ns0entity><ns0entity id="2003159" name="American Society">American Society</ns0entity><ns0entity id="2018964" name="Senior Management">Senior Management</ns0entity><ns0entity id="21835" name="Bristol Myers Squibb">Bristol Myers Squibb</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="70670" name="Annual Meeting">Annual Meeting</ns0entity><ns0entity id="2630043" name="EMD Serono">EMD Serono</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="89236" name="Nasdaq Composite">NASDAQ</ns0entity><ns0entity id="899771" name="Astellas Pharma">Astellas Pharma</ns0entity><ns0entity id="2014694" name="Clinical Development">Clinical Development</ns0entity><ns0entity id="2481724" name="Recent Business">Recent Business</ns0entity><ns0entity id="2014597" name="Management Team">Management Team</ns0entity><ns0entity id="481370" name="Bill Newell">Bill Newell</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>39.90750 116.39723</georss></item><item><title>Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones</title><link>https://www.marketscreener.com/quote/stock/SUTRO-BIOPHARMA-INC-46353309/news/Sutro-Biopharma-Reports-Full-Year-2022-Financial-Results-Business-Highlights-and-Select-Anticipated-43386347/</link><ns0keywords>vaxcyte common stock,million,select anticipated milestones,sutro biopharma reports,results,reports full year,full year 2022,clinical,year 2022 financial,greater china,company's,chief medical officer,business highlights</ns0keywords><pubDate>Thu, 30 Mar 2023 22:33:00 +0200</pubDate><guid isPermaLink="false">4-traders-71ce6f29fce3d9f067ff759ea88f7e47</guid><source country="FR" url="https://www.marketscreener.com/news/companies/">4-traders</source><ns1language>en</ns1language><category ns0trigger="pneumococcal[4]; ">PneumococcalInfection</category><category>GM_animals</category><category>CoronavirusInfection</category><ns0entity id="2174497" name="Strategic Communications">Strategic Communications</ns0entity><ns0entity id="380486" name="Drug Administration">Drug Administration</ns0entity><ns0entity id="719529" name="Carlos Lugo">Carlos Lugo</ns0entity><ns0entity id="2878445" name="Chief Business">Chief Business</ns0entity><ns0entity id="2003159" name="American Society">American Society</ns0entity><ns0entity id="2018964" name="Senior Management">Senior Management</ns0entity><ns0entity id="21835" name="Bristol Myers Squibb">Bristol Myers Squibb</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="70670" name="Annual Meeting">Annual Meeting</ns0entity><ns0entity id="2630043" name="EMD Serono">EMD Serono</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="89236" name="Nasdaq Composite">NASDAQ</ns0entity><ns0entity id="899771" name="Astellas Pharma">Astellas Pharma</ns0entity><ns0entity id="2014694" name="Clinical Development">Clinical Development</ns0entity><ns0entity id="2481724" name="Recent Business">Recent Business</ns0entity><ns0entity id="2014597" name="Management Team">Management Team</ns0entity><ns0entity id="481370" name="Bill Newell">Bill Newell</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>39.90750 116.39723</georss></item><item><title>Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones</title><link>https://www.streetinsider.com/Globe+Newswire/Sutro+Biopharma+Reports+Full+Year+2022+Financial+Results,+Business+Highlights+and+Select+Anticipated+Milestones/21444260.html</link><ns0keywords>vaxcyte common stock,million,select anticipated milestones,sutro biopharma reports,development,results,reports full year,full year 2022,clinical,greater china,year 2022 financial,recent business highlights,product candidates</ns0keywords><pubDate>Thu, 30 Mar 2023 22:31:00 +0200</pubDate><guid isPermaLink="false">streetinsider-f26f36cb64a44d2ab42ac7a24e447c71</guid><source country="US" url="https://www.streetinsider.com/Press+Releases">streetinsider</source><ns1language>en</ns1language><category ns0trigger="pneumococcal[4]; ">PneumococcalInfection</category><category>GM_animals</category><category>CoronavirusInfection</category><ns0entity id="380486" name="Drug Administration">Drug Administration</ns0entity><ns0entity id="719529" name="Carlos Lugo">Carlos Lugo</ns0entity><ns0entity id="2878445" name="Chief Business">Chief Business</ns0entity><ns0entity id="2003159" name="American Society">American Society</ns0entity><ns0entity id="2018964" name="Senior Management">Senior Management</ns0entity><ns0entity id="21835" name="Bristol Myers Squibb">Bristol Myers Squibb</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="70670" name="Annual Meeting">Annual Meeting</ns0entity><ns0entity id="2630043" name="EMD Serono">EMD Serono</ns0entity><ns0entity id="2103220" name="TPS">TPS</ns0entity><ns0entity id="89236" name="Nasdaq Composite">NASDAQ</ns0entity><ns0entity id="899771" name="Astellas Pharma">Astellas Pharma</ns0entity><ns0entity id="2014694" name="Clinical Development">Clinical Development</ns0entity><ns0entity id="2481724" name="Recent Business">Recent Business</ns0entity><ns0entity id="2014597" name="Management Team">Management Team</ns0entity><ns0entity id="481370" name="Bill Newell">Bill Newell</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>39.90750 116.39723</georss></item><item><title>Dati statistici globali del mercato Fieno alfalfa, struttura dei costi, analisi della domanda e dell’offerta entro il 2029</title><link>http://digitalesiciliana.com/2023/03/31/dati-statistici-globali-del-mercato-fieno-alfalfa-struttura-dei-costi-analisi-della-domanda-e-dellofferta-entro-il-2029/</link><ns0keywords>mercato fieno alfalfa,dati statistici globali,market,global,globali del mercato,report,ottieni un pdf,pdf di esempio,struttura dei costi,qiushi grass industry,rapporto di ricerca</ns0keywords><pubDate>Thu, 30 Mar 2023 20:43:00 +0200</pubDate><guid isPermaLink="false">digitalesiciliana-d9f93143a9a4641c0842d92809a13b43</guid><source country="IT" url="http://digitalesiciliana.com/">digitalesiciliana</source><ns1language>it</ns1language><category ns0trigger="Pneumococcal[1]; pneumococcal-vaccine-polyvalent-market-current-scenario-analysis-report-till-2029-2023-03-29[1]; ">PneumococcalInfection</category><category>Sodium</category><category>CoronavirusInfection</category><ns0entity id="3287664" name="Patch Market">Patch Market</ns0entity><ns0entity id="2546501" name="Energy Storage">Energy Storage</ns0entity><ns0entity id="2551695" name="Machine Market">Machine Market</ns0entity><ns0entity id="2530623" name="Devices Market">Devices Market</ns0entity><ns0entity id="2064597" name="Global Air">Global Air</ns0entity><ns0entity id="2575084" name="Treatment Market">Treatment Market</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><georss>39.90750 116.39723</georss></item><item><title>Vaccinazioni anti herpes zoster e anti pneumococco: per chi sono gratuite e come prenotare a Como</title><link>https://www.quicomo.it/attualita/vaccinazioni-anti-herpes-zoster-anti-pneumococco-chi-gratis-come-prenotare-a-como.html</link><ns0keywords>anti herpes zoster,vaccinazione anti pneumococco,prenotare a como,sistema sanitario regionale,regionale nei centri,vaccinazione anti herpes,zoster e anti,vaccinazioni anti herpes,dose,numero verde,seconda</ns0keywords><pubDate>Thu, 30 Mar 2023 17:57:00 +0200</pubDate><guid isPermaLink="false">quicomo-3875ce818d0acf0c5cc24497804a4b4d</guid><source country="IT" url="https://www.quicomo.it/rss">quicomo</source><ns1language>it</ns1language><category>VZV</category><category ns0trigger="Streptococcus[1]; pneumoniae[1]; pneumococco[8]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>HerpesZoster</category><category>Herpes</category><georss>44.47867 11.63812</georss></item><item><title>Ricerca di mercato Stampella all’avambraccio sul volume delle vendite, portata futura, progresso tecnologico durante il periodo di previsione dal 2023 al 2029</title><link>http://digitalesiciliana.com/2023/03/30/ricerca-di-mercato-stampella-allavambraccio-sul-volume-delle-vendite-portata-futura-progresso-tecnologico-durante-il-periodo-di-previsione-dal-2023-al-2029/</link><ns0keywords>mercato stampella all'avambraccio,rapporto,market,global,volume delle vendite,ricerca di mercato,medical,report,portata futura,periodo di previsione,ottieni un pdf,all'avambraccio sul volume,pdf di esempio</ns0keywords><pubDate>Thu, 30 Mar 2023 17:11:00 +0200</pubDate><guid isPermaLink="false">digitalesiciliana-2e95d8325be2b01a26ebdc59fa5ee9b6</guid><source country="IT" url="http://digitalesiciliana.com/">digitalesiciliana</source><ns1language>it</ns1language><category ns0trigger="Pneumococcal[1]; pneumococcal-vaccine-polyvalent-market-current-scenario-analysis-report-till-2029-2023-03-29[1]; ">PneumococcalInfection</category><category>orthopaedicdevices</category><category>Endocrine_disruptors</category><category>Sodium</category><ns0entity id="2569271" name="Platform Market">Platform Market</ns0entity><ns0entity id="2520178" name="Packaging Market">Packaging Market</ns0entity><ns0entity id="2599455" name="Lighting Market">Lighting Market</ns0entity><ns0entity id="2551695" name="Machine Market">Machine Market</ns0entity><ns0entity id="2530623" name="Devices Market">Devices Market</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2591753" name="Equipment Market">Equipment Market</ns0entity><georss>48.85341 2.34880</georss></item><item><title>Vaccinazione anti Herpes Zoster e anti - pneumococco gratuite nei centri delle Asst per over 65 e pazienti fragili</title><link>https://www.virgilio.it/italia/como/notizielocali/vaccinazione_anti_herpes_zoster_e_anti_pneumococco_gratuite_nei_centri_delle_asst_per_over_65_e_pazienti_fragili-70848390.html</link><ns0keywords>vaccinazione anti herpes,pazienti fragili,asst per over,centri delle asst,gratuite nei centri,zoster e anti</ns0keywords><pubDate>Thu, 30 Mar 2023 17:10:00 +0200</pubDate><guid isPermaLink="false">virgilio-5b8cab43cf4a8c8140e34074190b25f1</guid><source country="IT" url="https://www.virgilio.it/italia/ispra/notizielocali/tecnologia">virgilio</source><ns1language>it</ns1language><category>HerpesZoster</category><category>VZV</category><category>Herpes</category><category ns0trigger="pneumococco[2]; ">PneumococcalInfection</category></item><item><title>Vaccinazione anti Herpes Zoster e anti-pneumococco gratuite nei centri delle Asst per over 65 e pazienti fragili</title><link>https://www.espansionetv.it/2023/03/30/vaccinazione-anti-herpes-zoster-e-anti-pneumococco-gratuite-nei-centri-delle-asst-per-over-65-e-pazienti-fragili/</link><ns0keywords>pazienti fragili,gratuite nei centri,anti herpes zoster,asst per over,zoster e anti-pneumococco,vaccinazione anti herpes,vaccinali delle asst,over 65,l'herpes zoster,l'asst lariana invita,storia di herpes,patologia cardiovascolare severa,centri delle asst</ns0keywords><pubDate>Thu, 30 Mar 2023 16:39:00 +0200</pubDate><guid isPermaLink="false">espansionetv-d2142af9bea7c38e62392608fd05701a</guid><source country="IT" url="https://www.espansionetv.it/">espansionetv</source><ns1language>it</ns1language><category>VZV</category><category ns0trigger="Streptococcus[1]; pneumoniae[1]; pneumococco[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>HerpesZoster</category><category>Herpes</category></item><item><title>Aperte le prenotazioni per la vaccinazione anti-Herpes Zoster e anti-pneumococco</title><link>https://primacomo.it/attualita/aperte-le-prenotazioni-per-la-vaccinazione-anti-herpes-zoster-e-anti-pneumococco/</link><ns0keywords>anti herpes zoster,vaccinazione anti pneumococco,vaccinazione anti-herpes zoster,zoster e anti-pneumococco,sistema sanitario regionale,aperte le prenotazioni,regionale nei centri,vaccinazione anti herpes,dose,vaccinali delle asst,numero verde,patologia cardiovascolare severa,bpco e asma</ns0keywords><pubDate>Thu, 30 Mar 2023 16:26:00 +0200</pubDate><guid isPermaLink="false">giornaledicomo-00f591d8bf23ce7d2cb80026181d1a11</guid><source country="IT" url="https://primacomo.it">giornaledicomo</source><ns1language>it</ns1language><category>VZV</category><category ns0trigger="Streptococcus[1]; pneumoniae[1]; pneumococco[7]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>HerpesZoster</category><category>Herpes</category></item><item><title>Vaccinazione anti Herpes Zoster e anti pneumococco: dove, quando e perché farla</title><link>https://www.ciaocomo.it/2023/03/30/vaccinazione-anti-herpes-zoster-e-anti-pneumococco-dove-quando-e-perche-farla/251647/</link><ns0keywords>anti herpes zoster,vaccinazione anti pneumococco,lunedì al venerdì,vaccinazione anti herpes,seconda dose,zoster e anti,patologia cardiovascolare severa,numero verde,nati nel 1958,bpco e asma,2023 i nati,farla,attraverso il portale</ns0keywords><pubDate>Thu, 30 Mar 2023 15:46:00 +0200</pubDate><guid isPermaLink="false">ciaocomo-c41b80242767f07b98c34eb8eac9aaaa</guid><source country="IT" url="https://www.ciaocomo.it/feed/">ciaocomo</source><ns1language>it</ns1language><category>VZV</category><category ns0trigger="Streptococcus[1]; pneumoniae[1]; pneumococco[6]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>HerpesZoster</category><category>Herpes</category><georss>44.47867 11.63812</georss></item><item><title>Open day vaccinali per tutto il mese di aprile: anti Herpes Zoster, anti Pneumococco e anti Papilloma virus</title><link>https://www.varesenoi.it/2023/03/30/leggi-notizia/argomenti/salute-3/articolo/open-day-vaccinali-per-tutto-il-mese-di-marzo-anti-herpes-zoster-anti-pneumococco-e-anti-papilloma.html</link><ns0keywords>anti herpes zoster,open day vaccinali,anti papilloma virus,circolo di varese,terra della portineria,mese di aprile,anti pneumococco,viale borri,asst sette laghi,vaccinazioni,pneumococco e anti,dell'ospedale di circolo</ns0keywords><pubDate>Thu, 30 Mar 2023 15:27:00 +0200</pubDate><guid isPermaLink="false">varesenoi-092b1c6a5d8fbcc6fd477e7af603b6fb</guid><source country="IT" url="http://www.varesenoi.it/links/rss/argomenti/territorio/rss.xml">varesenoi</source><ns1language>it</ns1language><category>VZV</category><category ns0trigger="Pneumococco[1]; pneumococco[1]; ">PneumococcalInfection</category><category>HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><ns0entity id="2931927" name="Ospedale di Circolo">Ospedale di Circolo</ns0entity><ns0entity id="2058260" name="Sette Laghi">Sette Laghi</ns0entity><georss>45.82058 8.82511</georss></item><item><title>Open day vaccinali per tutto il mese di aprile: anti Herpes Zoster, anti Pneumococco e anti Papilloma virus</title><link>https://www.informazioneonline.it/2023/03/30/leggi-notizia/argomenti/salute-4/articolo/open-day-vaccinali-per-tutto-il-mese-di-marzo-anti-herpes-zoster-anti-pneumococco-e-anti-papilloma.html</link><ns0keywords>anti herpes zoster,open day vaccinali,anti papilloma virus,circolo di varese,terra della portineria,mese di aprile,anti pneumococco,viale borri,asst sette laghi,vaccinazioni,pneumococco e anti,dell'ospedale di circolo</ns0keywords><pubDate>Thu, 30 Mar 2023 15:18:00 +0200</pubDate><guid isPermaLink="false">informazioneonline-092b1c6a5d8fbcc6fd477e7af603b6fb</guid><source country="IT" url="https://www.informazioneonline.it/">informazioneonline</source><ns1language>it</ns1language><category>VZV</category><category ns0trigger="Pneumococco[1]; pneumococco[1]; ">PneumococcalInfection</category><category>HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><ns0entity id="2931927" name="Ospedale di Circolo">Ospedale di Circolo</ns0entity><ns0entity id="2058260" name="Sette Laghi">Sette Laghi</ns0entity><georss>45.82058 8.82511</georss></item><item><title>Open day vaccinali per tutto il mese di aprile a Varese: anti Herpes Zoster, anti Pneumococco e anti Papilloma virus</title><link>https://agenparl.eu/2023/03/30/open-day-vaccinali-per-tutto-il-mese-di-aprile-a-varese-anti-herpes-zoster-anti-pneumococco-e-anti-papilloma-virus/</link><ns0keywords>open day vaccinali,anti herpes zoster,mese di aprile,anti papilloma virus,pneumococco e anti,invio in allegato,sede vaccinale dell'ospedale,aprile a varese,fuoco di sant'antonio,partecipare agli open,dettagli per partecipare,dell'ospedale di circolo,anti pneumococco,allegato le locandine</ns0keywords><pubDate>Thu, 30 Mar 2023 15:13:00 +0200</pubDate><guid isPermaLink="false">agenparl-26fa94270655d2b419392b3c1102db73</guid><source country="IT" url="https://agenparl.eu/category/reg/feed/">agenparl</source><ns1language>it</ns1language><category>VZV</category><category ns0trigger="Pneumococco[1]; pneumococco[1]; ">PneumococcalInfection</category><category>HerpesZoster</category><category>vaccination_gen</category><category>Herpes</category><ns0entity id="2931927" name="Ospedale di Circolo">Ospedale di Circolo</ns0entity><ns0entity id="2058260" name="Sette Laghi">Sette Laghi</ns0entity><ns0entity id="2743700" name="Francesca Mauri">Francesca Mauri</ns0entity><georss>45.82058 8.82511</georss></item><item><title>Vaxcyte : Investor Presentation March 2023</title><link>https://www.marketscreener.com/quote/stock/VAXCYTE-INC-108367227/news/Vaxcyte-Investor-Presentation-March-2023-43382722/</link><ns0keywords>forward-looking statements,investor presentation march,vaxcyte's vaccine candidates,potential,vaxcyte,private securities litigation,vaxcyte's pcv franchise,including,presentation march 2023,litigation reform act,pneumococcal vaccine market,phase,vaxcyte's development programs</ns0keywords><pubDate>Thu, 30 Mar 2023 14:55:00 +0200</pubDate><guid isPermaLink="false">4-traders-f4422213ba7dcb4ee0c0a74706018a02</guid><source country="FR" url="https://www.marketscreener.com/rss/FeedNews.php">4-traders</source><ns1language>en</ns1language><category ns0trigger="Pneumococcal[2]; pneumococcal[3]; ">PneumococcalInfection</category><category>Shigellosis</category><category>Vaccination</category><category>CoronavirusInfection</category><category>Pneumococcus_Vaccine</category><ns0entity id="2900088" name="Key corporate">Key Corporate</ns0entity><ns0entity id="2186133" name="Innovation Company">Innovation Company</ns0entity><ns0entity id="2014597" name="Management Team">Management Team</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>20.65776 -74.95075</georss></item><item><title>Vaxcyte Doses First Participants in Phase 2 Study Evaluating VAX-24 for the Prevention of ...</title><link>https://www.eagletribune.com/region/vaxcyte-doses-first-participants-in-phase-2-study-evaluating-vax-24-for-the-prevention-of/article_e5f9ad84-3e6a-5da3-ad82-c5f4afdfb1bf.html</link><ns0keywords>vaxcyte,vax-24,phase 2 study,forward-looking statements,vaccine,pcv,prevention,timing,participants,ipd,evaluating,including</ns0keywords><pubDate>Thu, 30 Mar 2023 14:47:00 +0200</pubDate><guid isPermaLink="false">eagletribune-36422578ea5c7f622af869fe61cae436</guid><source country="US" url="http://www.eagletribune.com/search/?f=rss&amp;t=article&amp;c=&amp;l=50&amp;s=start_time&amp;sd=desc">eagletribune</source><ns1language>en</ns1language><category ns0trigger="Pneumococcal[2]; pneumococcus[1]; Streptococcus[1]; pneumoniae[1]; Pneumococci[1]; pneumococcal[5]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>Shigellosis</category><category>Meningitis</category><category>Vaccination</category><category>CoronavirusInfection</category><category>Immunization</category><category>Meningitis_Vaccine</category><category>Pneumococcus_Vaccine</category><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>38.89511 -77.03637</georss></item><item><title>Vaxcyte Doses First Participants in Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants</title><link>https://www.wallstreet-online.de/nachricht/16747917-vaxcyte-doses-first-participants-phase-2-study-evaluating-vax-24-for-the-prevention-of-invasive-pneumococcal-disease-infants</link><ns0keywords>invasive pneumococcal disease,prevention of invasive,infants,phase 2 study,san carlos,globe newswire,vaxcyte doses,study evaluating vax-24,pneumococcal conjugate vaccine,primary immunization series</ns0keywords><pubDate>Thu, 30 Mar 2023 14:43:00 +0200</pubDate><guid isPermaLink="false">wallstreet-online-1be76930b4fe91f9f1ff76ff04ed8b22</guid><source country="DE" url="https://www.wallstreet-online.de/rss/nachrichten-weitere-nachrichten.xml">wallstreet-online</source><ns1language>en</ns1language><category ns0trigger="Pneumococcal[1]; pneumococcal[2]; ">PneumococcalInfection</category><category>vaccination_gen</category><category>Vaccination</category><category>Immunization</category><category>Pneumococcus_Vaccine</category></item><item><title>Vaxcyte, Inc (PCVX) Doses First Participants in Phase 2 Study of VAX-24</title><link>https://www.streetinsider.com/Corporate+News/Vaxcyte%2C+Inc+%28PCVX%29+Doses+First+Participants+in+Phase+2+Study+of+VAX-24/21440029.html</link><ns0keywords>vaxcyte,pneumococcal disease,infants,forward-looking statements,phase 2 study,pcv,vaccine,timing,study of vax-24,pcvx,ipd</ns0keywords><pubDate>Thu, 30 Mar 2023 14:38:00 +0200</pubDate><guid isPermaLink="false">streetinsider-4f9ac8a2a8f60a69e011d7b63a86b8d9</guid><source country="US" url="https://www.streetinsider.com/">streetinsider</source><ns1language>en</ns1language><category ns0trigger="Pneumococcal[3]; pneumococcus[1]; Streptococcus[1]; pneumoniae[1]; Pneumococci[1]; pneumococcal[5]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>Shigellosis</category><category>Meningitis</category><category>Vaccination</category><category>CoronavirusInfection</category><category>Immunization</category><category>Meningitis_Vaccine</category><category>Pneumococcus_Vaccine</category><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>38.89511 -77.03637</georss></item><item><title>Vaxcyte Doses First Participants in Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants</title><link>https://www.streetinsider.com/Globe+Newswire/Vaxcyte+Doses+First+Participants+in+Phase+2+Study+Evaluating+VAX-24+for+the+Prevention+of+Invasive+Pneumococcal+Disease+in+Infants/21439954.html</link><ns0keywords>vaxcyte,infants,vax-24,forward-looking statements,pcv,phase 2 study,timing,invasive pneumococcal disease,vaccine,participants,ipd</ns0keywords><pubDate>Thu, 30 Mar 2023 14:34:00 +0200</pubDate><guid isPermaLink="false">streetinsider-0f9072271dde5a5376b48881641b0d09</guid><source country="US" url="https://www.streetinsider.com/Press+Releases">streetinsider</source><ns1language>en</ns1language><category ns0trigger="Pneumococcal[3]; pneumococcus[1]; Streptococcus[1]; Pneumococci[1]; pneumococcal[5]; ">PneumococcalInfection</category><category>Shigellosis</category><category>Meningitis</category><category>Vaccination</category><category>CoronavirusInfection</category><category>Immunization</category><category>Meningitis_Vaccine</category><category>Pneumococcus_Vaccine</category><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>38.89511 -77.03637</georss></item><item><title>Vaxcyte Doses First Participants in Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants</title><link>https://www.marketscreener.com/quote/stock/VAXCYTE-INC-108367227/news/Vaxcyte-Doses-First-Participants-in-Phase-2-Study-Evaluating-VAX-24-for-the-Prevention-of-Invasive-P-43382434/</link><ns0keywords>vaxcyte,invasive pneumococcal disease,infants,primary immunization series,vax-24,tolerability and immunogenicity,pcv,phase 2 study,forward-looking statements,safety,vaccine</ns0keywords><pubDate>Thu, 30 Mar 2023 14:31:00 +0200</pubDate><guid isPermaLink="false">4-traders-c6643bddef7f318a0983b49962cc7a3a</guid><source country="FR" url="https://www.marketscreener.com/rss/FeedNews.php">4-traders</source><ns1language>en</ns1language><category ns0trigger="Pneumococcal[4]; pneumococcus[1]; Streptococcus[1]; pneumoniae[1]; Pneumococci[1]; pneumococcal[5]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>Shigellosis</category><category>vaccination_gen</category><category>Meningitis</category><category>Vaccination</category><category>CoronavirusInfection</category><category>Immunization</category><category>VaccinationAdverseEffects</category><category>Meningitis_Vaccine</category><category>Pneumococcus_Vaccine</category><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2252063" name="Securities and Exchange Commission">Securities and Exchange Commission</ns0entity><georss>38.89511 -77.03637</georss></item><item><title>Pneumococcal Vaccine Market Report 2023: By Key Players, Trends, Size, Share and Forecast 2023-2029</title><link>https://www.openpr.com/news/2994766/pneumococcal-vaccine-market-report-2023-by-key-players</link><ns0keywords>pneumococcal vaccine market,company,share and forecast,key players,vaccine market report,trends,orion market research,market report 2023,size,million,type pneumococcal conjugate,prevnar 13</ns0keywords><pubDate>Thu, 30 Mar 2023 13:25:00 +0200</pubDate><guid isPermaLink="false">openpr-701c58744838ad79badcd078613176d6</guid><source country="DE" url="https://www.openpr.com/rss.xml">openpr</source><ns1language>en</ns1language><category ns0trigger="Pneumococcal[5]; pneumococcal-vaccine-market[1]; pneumococcal[8]; ">PneumococcalInfection</category><category>WHO</category><category>Vaccination</category><category>Pneumococcus_Vaccine</category><ns0entity id="2022524" name="Serum Institute">Serum Institute</ns0entity><ns0entity id="2318560" name="Sanofi S A">Sanofi SA</ns0entity><ns0entity id="2617219" name="National Biotec Group">National Biotec Group</ns0entity><ns0entity id="322433" name="GlaxoSmithKline">GlaxoSmithKline</ns0entity><ns0entity id="2049881" name="Pvt Ltd">Pvt. Ltd</ns0entity><ns0entity id="2252330" name="Merck &amp; Co">Merck &amp; Co</ns0entity><ns0entity id="2132265" name="Chinese company">Chinese company</ns0entity><ns0entity id="2533132" name="China National Biotec Group">China National Biotec Group</ns0entity><ns0entity id="2857472" name="Group company">Group Company</ns0entity><ns0entity id="2810054" name="Media Contact Company">Media Contact: Company</ns0entity><ns0entity id="2329618" name="Novavax Inc">Novavax, Inc</ns0entity><ns0entity id="2820857" name="Biotechnology Co Ltd">Biotechnology Co., Ltd</ns0entity><ns0entity id="2687931" name="America United">America United</ns0entity><ns0entity id="2598037" name="CSL Ltd">CSL Ltd</ns0entity><ns0entity id="10101" name="EU">European Union</ns0entity><ns0entity id="2645597" name="Walvax Biotechnology Co Ltd">Walvax Biotechnology Co., Ltd</ns0entity><ns0entity id="899771" name="Astellas Pharma">Astellas Pharma</ns0entity><ns0entity id="22487" name="World Health Organization">WHO</ns0entity><ns0entity id="86269" name="Pfizer Inc">Pfizer</ns0entity><ns0entity id="86269" name="Pfizer Inc">Pfizer Inc</ns0entity><ns0entity id="2020066" name="Age Group">Age Group</ns0entity><ns0entity id="2409720" name="North America United">North America United</ns0entity><georss>39.90750 116.39723</georss></item><item><title>General antimicrobial susceptibility data</title><link>https://www.esr.cri.nz/our-research/nga-kete/infectious-disease-intelligence/other-lab-surveillance/general-antimicrobial-susceptibility-data/</link><ns0keywords>general antimicrobial susceptibility,zealand,antimicrobial susceptibility data,bacteraemia,years of data,collected,visit the antimicrobial,streptococcus,testing in hospital,inclusive,susceptibility data generated,laboratories</ns0keywords><pubDate>Thu, 30 Mar 2023 10:21:00 +0200</pubDate><guid isPermaLink="false">surv-esr-cri-nz-49a4eaf05087613ccd58ba620e789f79</guid><source country="NZ" url="https://surv.esr.cri.nz/">surv-esr-cri-nz</source><ns1language>en</ns1language><category>HaemophilusinfluenzaeInfection</category><category ns0trigger="Streptococcus[2]; pneumoniae[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>EscherichiacoliInfection</category><category>Gonococcal</category><category>ArtificialTissuesAdverseEffects</category><georss>-41.28664 174.77557</georss></item><item><title>09:15 : A shkakton “syri rozë” ethe?</title><link>https://konica.al/2023/03/a-shkakton-syri-roze-ethe/</link><ns0keywords>ethe,shkakton syri rozë,a shkakton syri,sy rozë,sytë,simptomat e syrit,konjuktiviti,infeksion,e syrit rozë,bakterial,temperaturës</ns0keywords><pubDate>Thu, 30 Mar 2023 09:17:00 +0200</pubDate><guid isPermaLink="false">konica-807127090e093dcfb408a6bdcc73cca6</guid><source country="AL" url="https://konica.al/">konica</source><ns1language>sq</ns1language><category>HaemophilusinfluenzaeInfection</category><category ns0trigger="Streptococcus[1]; pneumoniae[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>MedicinalXucts</category></item><item><title>Estreptococos • Síntomas, Infección y Terapia</title><link>https://nuevoperiodico.com/estreptococos-sintomas-infeccion-y-terapia/</link><ns0keywords>personas,garganta,estreptococos • síntomas,grupo,infección y terapia,enfermedad,descripción y clasificación,streptococcus,escarlatina,estreptocócica</ns0keywords><pubDate>Thu, 30 Mar 2023 08:09:00 +0200</pubDate><guid isPermaLink="false">nuevoperiodico-4724d0022a4e874f6cbe64c5c4fa4b56</guid><source country="ES" url="https://nuevoperiodico.com/">nuevoperiodico</source><ns1language>es</ns1language><category ns0trigger="Streptococcus[5]; pneumoniae[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>BloodProducts</category><category>Vomiting</category><category>MedicinalXucts</category><category>Antimicrobialresist</category><category>BloodProductsAdverseEffects</category><category>ArtificialTissuesAdverseEffects</category><ns0entity id="41606" name="Robert Koch Institute">Robert Koch</ns0entity><ns0entity id="41606" name="Robert Koch Institute">Instituto Robert Koch</ns0entity></item><item><title>Meningite bacteriana mata 7 em cada 10 infetados. "Qualquer pessoa pode vir a ter uma meningite no decurso da sua vida"</title><link>https://lifestyle.sapo.pt/saude/noticias-saude/artigos/meningite-bacteriana-mata-7-em-cada-10-infetados-qualquer-pessoa-pode-vir-a-ter-uma-meningite-no-decurso-da-sua-vida</link><ns0keywords>qualquer pessoa,meningite bacteriana mata,doença,pessoa pode vir,adolescentes,meningite no decurso,vacina,sociedade portuguesa,bacteriana mata 7,adultos,10 infetados,vida,meningococo</ns0keywords><pubDate>Thu, 30 Mar 2023 08:07:00 +0200</pubDate><guid isPermaLink="false">sapo-3f87cf252dac6010e109fefd34ab2c1c</guid><source country="PT" url="https://www.sapo.pt/">sapo</source><ns1language>pt</ns1language><category>HaemophilusinfluenzaeInfection</category><category ns0trigger="Streptococcus[1]; pneumoniae[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>EMA</category><category>MedicinalXucts</category><category>vaccination_gen</category><category>Meningitis</category><category>VaccinationAdverseEffects</category><ns0entity id="2107966" name="PNV">PNV</ns0entity><georss>18.48333 -69.93333</georss></item><item><title>Covid. How to proceed with vaccinations. WHO indications: “New booster within 6-12 months of the last dose for people at risk”</title><link>https://www.breakinglatest.news/health/covid-how-to-proceed-with-vaccinations-who-indications-new-booster-within-6-12-months-of-the-last-dose-for-people-at-risk/</link><ns0keywords>high priority group,risk,covid,proceed with vaccinations,children,priority group includes,booster,people,medium priority groups,dose,months,indications,low</ns0keywords><pubDate>Thu, 30 Mar 2023 05:21:00 +0200</pubDate><guid isPermaLink="false">breakinglatest-ba41698b429977255a242bb33f0cd927</guid><source country="US" url="https://www.breakinglatest.news/category/business/">breakinglatest</source><ns1language>en</ns1language><category>Measles</category><category ns0trigger="pneumococcus[1]; ">PneumococcalInfection</category><category>Immunization</category><category>Rotavirus</category><category>Communicabledisease</category><category>Epidemic</category><category>CoronavirusInfection</category><category>vaccination_gen</category><category>WHO</category><category>VaccinationAdverseEffects</category><ns0entity id="22487" name="World Health Organization">WHO</ns0entity><ns0entity id="2528522" name="Coronavirus">Covid</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="1579495" name="Hanna Nohynek">Hanna Nohynek</ns0entity></item><item><title>Expression of Concern With Regards to the Current Stages of Avian Influenza A (H5N1) Zoonotic Spillover Into Humans</title><link>https://www.preprints.org/manuscript/202303.0477/v1</link><ns0keywords>zoonotic spillover,current stages,expression of concern,iav,avian influenza,virus,stages of avian,spillover into humans,influenza a h5n1,infection,world health organization,immune</ns0keywords><pubDate>Thu, 30 Mar 2023 05:09:00 +0200</pubDate><guid isPermaLink="false">jstage-biology-f9aaf1fa7233da7555955c2998002106</guid><source country="JP" url="https://www.preprints.org/subject/browse/biology">jstage-biology</source><ns1language>en</ns1language><category ns0trigger="Streptococcus[1]; pneumoniae[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>SwineFlu</category><category>Influenza</category><category>Epidemic</category><category>CoronavirusInfection</category><category>HaemophilusinfluenzaeInfection</category><category>WHO</category><ns0entity id="3113435" name="Creative Commons">Creative Commons</ns0entity><ns0entity id="22487" name="World Health Organization">World Health Organization</ns0entity></item><item><title>24 de abril: D�a Mundial contra la Meningitis</title><link>https://www.sap.org.ar/novedades/552/24-de-abril-dia-mundial-contra-la-meningitis.html</link><ns0keywords>meningitis,vacunación,vacuna,24 de abril,calendario nacional,d�a mundial,dosis,mundo que constituye,meses,enfermedad prevalente,emergencia médica,años,haemophilus influenzae tipo,constituye una emergencia</ns0keywords><pubDate>Thu, 30 Mar 2023 03:05:00 +0200</pubDate><guid isPermaLink="false">sap-9284fa28875ecc4fe80ac836434986e9</guid><source country="AR" url="http://sap.org.ar/">sap</source><ns1language>es</ns1language><category ns0trigger="Streptococcus[2]; pneumoniae[2]; Streptococcus pneumoniae[2]; ">PneumococcalInfection</category><category>Vaccination</category><category>Epidemic</category><category>Meningitis</category><category>HaemophilusinfluenzaeInfection</category><category>WHO</category><category>Meningitis_Vaccine</category><category>HaemophilusInfluenzae_Vaccine</category><category>Pneumococcus_Vaccine</category><ns0entity id="22487" name="World Health Organization">Organización Mundial de la Salud</ns0entity><ns0entity id="22487" name="World Health Organization">OMS</ns0entity><ns0entity id="2084787" name="Argentina de Pediatría">Argentina de Pediatría</ns0entity><georss>18.48333 -69.93333</georss></item><item><title>Criança morre com suspeita de meningoencefalite no Hospital da Restauração</title><link>https://jc.ne10.uol.com.br/colunas/saude-e-bem-estar/2023/03/15209120-crianca-morre-com-suspeita-de-meningoencefalite-no-hospital-da-restauracao.html</link><ns0keywords>hospital da restauração,suspeita de meningoencefalite,criança morre,meningoencefalite no hospital,reportagem em atualização,morreu com suspeita,morre com suspeita,haemophilus influenzae,neisseria meningitides,ses-pe,menino de 10,estadual de saúde,atualização um menino,morava em camaragibe,vigilância epidemiológica hospitalar</ns0keywords><pubDate>Wed, 29 Mar 2023 21:24:00 +0200</pubDate><guid isPermaLink="false">jconline-1e853aee4d9d2f1fded52915b6382269</guid><source country="BR" url="https://jconline.ne10.uol.com.br/">jconline</source><ns1language>pt</ns1language><category ns0trigger="Streptococcus[1]; pneumoniae[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>Epidemic</category><category>HaemophilusinfluenzaeInfection</category><ns0entity id="2519910" name="O hospital">O Hospital</ns0entity><georss>-8.05389 -34.88111</georss></item><item><title>GSK CEO Emma Walmsley On RSV Vaccines</title><link>https://www.valuewalk.com/gsk-ceo-emma-walmsley-on-rsv-vaccines/</link><ns0keywords>people,year,emma walmsley,diseases,cramer,walmsley on rsv,vaccine,rsv vaccines,great,innovation,industry,gsk ceo emma</ns0keywords><pubDate>Wed, 29 Mar 2023 21:13:00 +0200</pubDate><guid isPermaLink="false">valuewalk-d203e62ebd570f2c36a3e887fefb8744</guid><source country="US" url="https://www.valuewalk.com/feed/">valuewalk</source><ns1language>en</ns1language><category ns0trigger="pneumococcal[2]; ">PneumococcalInfection</category><category>AIDS-HIV</category><category>Communicabledisease</category><category>Influenza</category><category>Meningitis</category><category>HerpesZoster</category><category>VZV</category><category>Antimicrobialresist</category><ns0entity id="2094664" name="Silicon Valley Bank">Silicon Valley Bank</ns0entity><ns0entity id="100120" name="Magic Johnson">Magic Johnson</ns0entity><ns0entity id="2003605" name="Emma Walmsley">Emma Walmsley</ns0entity><ns0entity id="2003605" name="Emma Walmsley">EMMA WALMSLEY</ns0entity><ns0entity id="2151307" name="radical">radical</ns0entity><ns0entity id="2528522" name="Coronavirus">Covid</ns0entity><ns0entity id="95342" name="Irish Republican Army">IRA</ns0entity><georss>39.90750 116.39723</georss></item><item><title>Study offers a novel therapeutic option to combat antibiotic-resistant pneumonia</title><link>https://www.news-medical.net/news/20230329/Study-offers-a-novel-therapeutic-option-to-combat-antibiotic-resistant-pneumonia.aspx</link><ns0keywords>combat antibiotic-resistant pneumonia,therapeutic option,study offers,fda-approved drug,erythromycin,antibiotic,united states food,plos biology,option to combat,bacteria,pneumoniae have made,fomepizole,increases in multidrug-resistance,including</ns0keywords><pubDate>Wed, 29 Mar 2023 21:11:00 +0200</pubDate><guid isPermaLink="false">newsmedical-68a695b65ec44fe2fec7b21ecc7cea4c</guid><source country="US" url="https://www.news-medical.net/syndication.axd">newsmedical</source><ns1language>en</ns1language><category ns0trigger="S. pneumoniae[9]; Streptococcus[3]; pneumoniae[10]; pneumococcal[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category><category>MRSA</category><ns0entity id="2748936" name="University of Alabama">University of Alabama</ns0entity><ns0entity id="380486" name="Drug Administration">Drug Administration</ns0entity></item><item><title>Женщина облизывала собственные фекалии и 5 раз заразилась стрептококком: зачем она это делала</title><link>https://tsn.ua/ru/tsikavinki/zhenschina-oblizyvala-sobstvennye-fekalii-i-5-raz-zarazilas-streptokokkom-zachem-ona-eto-delala-2296441.html</link><ns0keywords>женщина облизывала собственные,заразилась стрептококком,штат калифорния,стелла бери ошарашила,рассказала,фекалии и 5,облизывала собственные фекалии,делала,5 раз заразилась,звезда onlyfans,людей,onlyfans из лос-анджелеса</ns0keywords><pubDate>Wed, 29 Mar 2023 21:04:00 +0200</pubDate><guid isPermaLink="false">kyiv-38ecade25c4076ac1fa9d4b071de5826</guid><source country="UA" url="https://kyiv.tsn.ua/ru">kyiv</source><ns1language>ru</ns1language><category ns0trigger="стрептококком[3]; ">PneumococcalInfection</category><georss>37.25022 -119.75126</georss></item><item><title>Женщина облизывала собственные фекалии и 5 раз заразилась стрептококком: зачем она это делала</title><link>https://tsn.ua/ru/tsikavinki/zhenschina-oblizyvala-sobstvennye-fekalii-i-5-raz-zarazilas-streptokokkom-zachem-ona-eto-delala-2296441.html</link><ns0keywords>женщина облизывала собственные,заразилась стрептококком,штат калифорния,стелла бери ошарашила,рассказала,фекалии и 5,облизывала собственные фекалии,делала,5 раз заразилась,звезда onlyfans,людей,onlyfans из лос-анджелеса</ns0keywords><pubDate>Wed, 29 Mar 2023 21:01:00 +0200</pubDate><guid isPermaLink="false">tsn-ua-ru-38ecade25c4076ac1fa9d4b071de5826</guid><source country="UA" url="https://tsn.ua/ru">tsn-ua-ru</source><ns1language>ru</ns1language><category ns0trigger="стрептококком[3]; ">PneumococcalInfection</category><georss>37.25022 -119.75126</georss></item><item><title>Женщина облизывала собственные фекалии и 5 раз заразилась стрептококком: зачем она это делала</title><link>https://tsn.ua/ru/tsikavinki/zhenschina-oblizyvala-sobstvennye-fekalii-i-5-raz-zarazilas-streptokokkom-zachem-ona-eto-delala-2296441.html</link><ns0keywords>женщина облизывала собственные,заразилась стрептококком,штат калифорния,стелла бери ошарашила,рассказала,фекалии и 5,облизывала собственные фекалии,делала,5 раз заразилась,звезда onlyfans,людей,onlyfans из лос-анджелеса</ns0keywords><pubDate>Wed, 29 Mar 2023 21:01:00 +0200</pubDate><guid isPermaLink="false">lviv-38ecade25c4076ac1fa9d4b071de5826</guid><source country="UA" url="https://lviv.tsn.ua/ru">lviv</source><ns1language>ru</ns1language><category ns0trigger="стрептококком[3]; ">PneumococcalInfection</category><georss>37.25022 -119.75126</georss></item><item><title>Honor Roll</title><link>https://www.hhs.nd.gov/health/diseases-conditions-and-immunization/immunizations/honor-roll</link><ns0keywords>north dakota immunization,immunization honor roll,met or exceeded,dakota immunization program,healthy people,quarter,years,infants,recognize those providers,coverage,people 2020 goal,doses</ns0keywords><pubDate>Wed, 29 Mar 2023 20:16:00 +0200</pubDate><guid isPermaLink="false">health-nd-28804164ad47cba6e5e4d0d6ef89c7f2</guid><source country="US" url="https://www.health.nd.gov/rss/news">health-nd</source><ns1language>en</ns1language><category>Measles</category><category ns0trigger="Pneumococcal[2]; ">PneumococcalInfection</category><category>Vaccination</category><category>HPV</category><category>HepatitisB</category><category>Immunization</category><category>Influenza</category><category>vaccination_gen</category><category>Poliomyelitis</category><category>HepatitisB_Vaccine</category><category>Measles_Vaccine</category><category>Poliomyelitis_Vaccine</category><category>HPV_Vaccine</category><category>Pneumococcus_Vaccine</category><category>Influenza_Vaccine</category><ns0entity id="2720609" name="Immunization Program">Immunization Program</ns0entity><ns0entity id="1031908" name="Honor Roll">Honor Roll</ns0entity><georss>47.50027 -100.00068</georss></item><item><title>علاج البلغم: أفضل الطرق الطبيعية</title><link>https://www.almayadeen.net/health/علاج-البلغم:-أفضل-الطرق-الطبيعية</link><ns0keywords>طول الجهاز التنفسي,علاج البلغم بالاعشاب,الحلق,البلغم ومشاكل الجهاز,منقوع الزعتر والعسل,السعال,تقليل إفراز البلغم,سهلة التحضير علاج,البلغم بشكل طبيعي,الأنف,حماية الجسم,الراحة وفقدان الشهية</ns0keywords><pubDate>Wed, 29 Mar 2023 19:41:00 +0200</pubDate><guid isPermaLink="false">almayadeen-f3b2436334c699f495d770defa04dfd4</guid><source country="IR" url="https://www.almayadeen.net">almayadeen</source><ns1language>ar</ns1language><category>MedicinalXucts</category><category ns0trigger="الرئوي[3]; الالتهاب الرئوي[2]; ">PneumococcalInfection</category><georss>34.64010 50.87640</georss></item><item><title>Dati statistici globali del mercato Gruppi di cavi coassiali RF, struttura dei costi, analisi della domanda e dell’offerta entro il 2029</title><link>http://digitalesiciliana.com/2023/03/29/dati-statistici-globali-del-mercato-gruppi-di-cavi-coassiali-rf-struttura-dei-costi-analisi-della-domanda-e-dellofferta-entro-il-2029-2/</link><ns0keywords>gruppi di cavi,rapporto,dati statistici globali,market,cavi coassiali rf,mercato gruppi,global,globali del mercato,report,ottieni un pdf,struttura dei costi,pdf di esempio</ns0keywords><pubDate>Wed, 29 Mar 2023 19:19:00 +0200</pubDate><guid isPermaLink="false">digitalesiciliana-cfa06123366a26a2c438e436de758eb4</guid><source country="IT" url="http://digitalesiciliana.com/">digitalesiciliana</source><ns1language>it</ns1language><category ns0trigger="Pneumococcal[1]; pneumococcal-testing-market-demographic-trends-from-2023-to-2029-2023-03-28[1]; ">PneumococcalInfection</category><category>Methyl</category><category>CoronavirusInfection</category><ns0entity id="2482085" name="Mass Transfer">Mass Transfer</ns0entity><ns0entity id="2295658" name="Technology Co Ltd">Technology Co., Ltd</ns0entity><ns0entity id="2551695" name="Machine Market">Machine Market</ns0entity><ns0entity id="2373102" name="Catering Services">Catering Services</ns0entity><ns0entity id="2160683" name="Drive Systems">Drive Systems</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2434632" name="Control Systems">Control Systems</ns0entity><ns0entity id="2591753" name="Equipment Market">Equipment Market</ns0entity><ns0entity id="458864" name="Sumitomo Metal Mining">Sumitomo</ns0entity><ns0entity id="2599455" name="Lighting Market">Lighting Market</ns0entity><ns0entity id="2600222" name="Vehicle Market">Vehicle Market</ns0entity><ns0entity id="2006503" name="Power Bank">Power Bank</ns0entity><ns0entity id="2673970" name="Technology Co">Technology Co</ns0entity><georss>36.60000 140.65000</georss></item><item><title>Հայմորիտը մանկության շրջանում տարածված հիվանդություն է, որի ժամանակ առաջանում է դիմածնոտային սինուսների լորձաթաղանթի բորբոքում (հաճախ թարախային)։</title><link>https://www.aysor.am/am/news/2023/03/29/haymorit/2072439</link><ns0keywords>շրջանում տարածված հիվանդություն,հայմորիտը մանկության շրջանում,դիմածնոտային սինուսների լորձաթաղանթի,տարածված հիվանդություն է,մանկության շրջանում տարածված,ցավը հաճախ առաջանում,հայմորիտը երեխային բերում,դիմածնոտային սինուսներից թարախային,սինուսների լորձաթաղանթի բորբոքում,կյանքի որակ բաժնի,քթի մաքսիլյար սինուսներ,լորձաթաղանթի բորբոքում հաճախ,քթի միջնապատի շեղումից</ns0keywords><pubDate>Wed, 29 Mar 2023 19:17:00 +0200</pubDate><guid isPermaLink="false">aysor-am-8aa8e531675ca33531d87501056665fe</guid><source country="AM" url="https://www.aysor.am/am/news/armenia">aysor-am</source><ns1language>hy</ns1language><category>CoronavirusInfection</category><category ns0trigger="pneumococcus[1]; streptococcus[1]; ">PneumococcalInfection</category><category>HaemophilusinfluenzaeInfection</category></item><item><title>Ковид устроил революцию в мире вирусов: грипп теперь ведет себя совершенно иначе, а заражения грибковыми заболеваниями выглядят жутко</title><link>https://nv-online.info/kovid-ustroil-revoljuciju-v-mire-virusov-gripp-teper-vedet-sebja-sovershenno-inache-a-zarazhenija-gribkovymi-zabolevanijami-vygljadjat-zhutko.html</link><ns0keywords>ковид устроил революцию,заражения грибковыми заболеваниями,заболеваниями выглядят жутко,революцию в мире,мире вирусов,детей,денис усенко,грипп,пандемии,совершенно иначе,гриппа,юрий лобзин</ns0keywords><pubDate>Wed, 29 Mar 2023 18:47:00 +0200</pubDate><guid isPermaLink="false">nv-online-52f1c4248ce3c2c90743127dc038e52d</guid><source country="BY" url="https://nv-online.info/">nv-online</source><ns1language>ru</ns1language><category>Measles</category><category>RespiratorySyndrome</category><category ns0trigger="стрептококковой[1]; стрептококковая[1]; ">PneumococcalInfection</category><category>Influenza</category><category>Epidemic</category><category>CoronavirusInfection</category><category>RashSyndrome</category><category>vaccination_gen</category><category>Communicabledisease</category><ns0entity id="954170" name="Анна Попова">Анна Попова</ns0entity><ns0entity id="3017333" name="Елена Дондурей">Елена Дондурей</ns0entity><ns0entity id="2579483" name="Юрий Лобзин">Юрий Лобзин</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity></item><item><title>29-Mar-2023 Fomepizole helps overcome antibiotic-resistant pneumonia in mice University of Alabama at Birmingham Peer-Reviewed Publication Researchers report a new target to fight against pneumonia due to infections by the drug-resistant opportunistic lung pathogen Streptococcus pneumoniae — interference with the bacteria’s fermentation metabolism.</title><link>https://www.eurekalert.org/news-releases/984375</link><ns0keywords>opportunistic lung pathogen,target to fight,university of alabama,fight against pneumonia,publication researchers report,birmingham peer-reviewed publication,fomepizole,alabama at birmingham,bacteria's fermentation metabolism,plos biology,pneumonia due,overcome antibiotic-resistant pneumonia,due to infections,streptococcus pneumoniae interference</ns0keywords><pubDate>Wed, 29 Mar 2023 18:33:00 +0200</pubDate><guid isPermaLink="false">eurekalert-2f7783586180345e5a21eac72d92c4c0</guid><source country="US" url="https://www.eurekalert.org/news-releases/browse">eurekalert</source><ns1language>en</ns1language><category ns0trigger="S. pneumoniae[9]; Streptococcus[4]; pneumoniae[11]; pneumococcal[1]; Streptococcus pneumoniae[2]; ">PneumococcalInfection</category><ns0entity id="2748936" name="University of Alabama">University of Alabama</ns0entity><ns0entity id="380486" name="Drug Administration">Drug Administration</ns0entity><georss>52.48142 -1.89983</georss></item><item><title>Le fomépizole aide à vaincre la pneumonie résistante aux antibiotiques chez la souris – Actualités</title><link>https://www.nouvelles-du-monde.com/le-fomepizole-aide-a-vaincre-la-pneumonie-resistante-aux-antibiotiques-chez-la-souris-actualites/</link><ns0keywords>pneumoniae,fomépizole,pneumonie résistante,pathogène pulmonaire opportuniste,aide à vaincre,lexi coon l'augmentation,vaincre la pneumonie,souris actualités,orihuela,résistante aux antibiotiques,streptococcus,nouvelle cible</ns0keywords><pubDate>Wed, 29 Mar 2023 16:57:00 +0200</pubDate><guid isPermaLink="false">nouvelles-du-monde-b57e3b7cdd62610856ec5e80e13024fa</guid><source country="FR" url="https://www.nouvelles-du-monde.com/">nouvelles-du-monde</source><ns1language>fr</ns1language><category ns0trigger="S. pneumoniae[9]; Streptococcus[5]; pneumoniae[12]; pneumococcique[1]; Streptococcus pneumoniae[3]; ">PneumococcalInfection</category><category>Multidrugresistant</category><category>Pathogen-of-war</category><category>MedicinalXucts</category><ns0entity id="380486" name="Drug Administration">Drug Administration</ns0entity><ns0entity id="2939025" name="Marnix E Heersink">Marnix E. Heersink</ns0entity><georss>52.48142 -1.89983</georss></item><item><title>全球首款双载体13价肺炎球菌多糖结合疫苗北京开打</title><link>https://www.stcn.com/article/detail/828441.html</link><ns0keywords>全球首款双载体13价肺炎球菌多糖结合疫苗北京开打</ns0keywords><pubDate>Wed, 29 Mar 2023 16:27:00 +0200</pubDate><guid isPermaLink="false">stcn-00f7b7780838e4af34bf7245d21bf0f7</guid><source country="CN" url="https://www.stcn.com/">stcn</source><ns1language>zh</ns1language><category>Pneumonia</category><category>Immunization</category><category ns0trigger="肺炎球菌[3]; ">PneumococcalInfection</category><georss>39.90750 116.39723</georss></item><item><title>Pneumococcal Disease</title><link>https://www.healthvermont.gov/disease-control/other-diseases/pneumococcal-disease</link><ns0keywords>pneumococcal disease,streptococcus pneumoniae,pneumonia,years,disease is caused,bacteria,types,called pneumococcus,common,infection,bacterium,variety of infections</ns0keywords><pubDate>Wed, 29 Mar 2023 16:04:00 +0200</pubDate><guid isPermaLink="false">healthvermont-c32e249ae14f7334bb41eec43c58ec73</guid><source country="US" url="https://www.healthvermont.gov/media/newsroom/2020-news-releases">healthvermont</source><ns1language>en</ns1language><category>Pneumonia</category><category ns0trigger="Pneumococcal[6]; pneumococcus[2]; S. pneumoniae[1]; Streptococcus[1]; pneumoniae[2]; pneumococcal[15]; Pneumococcus[1]; Streptococcus pneumoniae[1]; ">PneumococcalInfection</category></item><item><title>Vaccines, Vol. 11, Pages 760: Influenza, Pneumococcal and Herpes Zoster Vaccination Rates in Patients with Autoimmune Inflammatory Rheumatic Diseases</title><link>https://www.mdpi.com/2076-393X/11/4/760</link><ns0keywords>streptococcus pneumoniae,influenza,autoimmune inflammatory rheumatic,herpes zoster,vol,vaccines,vaccination rates,patients with autoimmune,inflammatory rheumatic diseases,aiird,pneumococcal,pages 760</ns0keywords><pubDate>Wed, 29 Mar 2023 14:51:00 +0200</pubDate><guid isPermaLink="false">mdpi-b4c6604e02d3db85bfb4a1c33ee70222</guid><source country="CH" url="https://www.mdpi.com/rss">mdpi</source><ns1language>en</ns1language><category>HerpesZoster</category><category>VZV</category><category>CoronavirusInfection</category><category>Herpes</category><category ns0trigger="Pneumococcal[1]; Streptococcus[4]; pneumoniae[4]; pneumococcal[5]; Streptococcus pneumoniae[4]; ">PneumococcalInfection</category><category>Influenza</category><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><georss>52.52437 13.41053</georss></item><item><title>SANT’ANGELO Ricoverata una donna colpita da meningite da pneumococco</title><link>https://www.ilcittadino.it/stories/centro_lodigiano/santangelo-ricoverata-una-donna-colpita-da-meningite-da-pneumococco_88416_96/</link><ns0keywords>ricoverata una donna,meningite da pneumococco,reparto infettivi dell'ospedale,sant'angelo ricoverata,ricoverato nel reparto,provincia di lodi,donna colpita,malattia,l'appello al vaccino,colpita da meningite,meningite pneumococcica,casi,dell'ospedale di sant'angelo</ns0keywords><pubDate>Wed, 29 Mar 2023 09:17:00 +0200</pubDate><guid isPermaLink="false">ilcittadino-2fc164f0d50227c019d4f3c71b6cad24</guid><source country="IT" url="https://www.ilcittadino.it/">ilcittadino</source><ns1language>it</ns1language><category>Encephalitis</category><category ns0trigger="pneumococcica[3]; pneumococco[1]; ">PneumococcalInfection</category><category>ViralEncephalitis</category><georss>45.30989 9.50085</georss></item><item><title>Clover Announces Corporate Updates and Full Year 2022 Financial Results</title><link>https://www.marketscreener.com/quote/stock/CLOVER-BIOPHARMACEUTICALS-128691300/news/Clover-Announces-Corporate-Updates-and-Full-Year-2022-Financial-Results-43362093/</link><ns0keywords>clover,china,leading respiratory vaccine,announces corporate updates,results,respiratory vaccine franchise,full year,million,quadrivalent seasonal influenza,forward-looking statements,year 2022 financial,vaccines</ns0keywords><pubDate>Wed, 29 Mar 2023 03:35:00 +0200</pubDate><guid isPermaLink="false">4-traders-538c5eddfcbe31a4e4ed62f993973eaa</guid><source country="FR" url="https://www.marketscreener.com/news/companies/press_release/">4-traders</source><ns1language>en</ns1language><category>FoodFeedGMO</category><category ns0trigger="pneumococcus[1]; ">PneumococcalInfection</category><category>Influenza</category><category>Communicabledisease</category><category>Vaccination</category><category>RespiratorySyncytialVirusInfection</category><category>vaccination_gen</category><category>Immunization</category><category>CoronavirusInfection</category><category>Pneumococcus_Vaccine</category><category>Influenza_Vaccine</category><ns0entity id="171249" name="International Financial Reporting Standards">International Financial Reporting Standards</ns0entity><ns0entity id="2546802" name="Clover Biopharmaceuticals">Clover Biopharmaceuticals</ns0entity><ns0entity id="26245" name="The Lancet">The Lancet</ns0entity><ns0entity id="10101" name="EU">European Union</ns0entity><ns0entity id="10101" name="EU">EU</ns0entity><ns0entity id="2132265" name="Chinese company">Chinese company</ns0entity><ns0entity id="2977238" name="Omicron">Omicron</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2579691" name="Vaccine Development">Vaccine Development</ns0entity><ns0entity id="2550088" name="Joshua Liang">Joshua Liang</ns0entity><ns0entity id="2871125" name="Director Corporate">Director, Corporate</ns0entity><georss>9.55060 122.51640</georss></item><item><title>Clover Announces Corporate Updates and Full Year 2022 Financial Results</title><link>https://www.asiaone.com/business/clover-announces-corporate-updates-and-full-year-2022-financial-results</link><ns0keywords>clover,china,seasonal influenza,market,leading respiratory vaccine,announces corporate updates,results,clover's,full year,million,covid-19 vaccine,forward-looking statements,year 2022 financial</ns0keywords><pubDate>Wed, 29 Mar 2023 02:23:00 +0200</pubDate><guid isPermaLink="false">AsiaOne-56dc47514db0effb8478f51301d51ac8</guid><source country="SG" url="https://www.asiaone.com/business">AsiaOne</source><ns1language>en</ns1language><category>FoodFeedGMO</category><category ns0trigger="pneumococcus[1]; ">PneumococcalInfection</category><category>Influenza</category><category>Communicabledisease</category><category>Vaccination</category><category>RespiratorySyncytialVirusInfection</category><category>vaccination_gen</category><category>Immunization</category><category>CoronavirusInfection</category><category>Pneumococcus_Vaccine</category><category>Influenza_Vaccine</category><ns0entity id="171249" name="International Financial Reporting Standards">International Financial Reporting Standards</ns0entity><ns0entity id="2546802" name="Clover Biopharmaceuticals">Clover Biopharmaceuticals</ns0entity><ns0entity id="26245" name="The Lancet">The Lancet</ns0entity><ns0entity id="10101" name="EU">European Union</ns0entity><ns0entity id="10101" name="EU">EU</ns0entity><ns0entity id="2132265" name="Chinese company">Chinese company</ns0entity><ns0entity id="2977238" name="Omicron">Omicron</ns0entity><ns0entity id="2528522" name="Coronavirus">COVID-19</ns0entity><ns0entity id="2579691" name="Vaccine Development">Vaccine Development</ns0entity><ns0entity id="2550088" name="Joshua Liang">Joshua Liang</ns0entity><ns0entity id="2871125" name="Director Corporate">Director, Corporate</ns0entity><georss>31.22222 121.45806</georss></item></data>